Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000221119

Medchemexpress LLC N2-{[1-ethyl-6-(4-methylphenoxy)-1H-benzimidazol-2-yl]methyl}-L-alanineamide | 1233229-75-8 | 99.4% | 352.43 g/mol | C20H24N4O2 | 5 MG
SDP

Catalog No. 5000221119
Encompass_Preferred

Bliretrigine is a research-stage sodium channel blocker supplied for laboratory studies of pain and neuronal function. It is provided in high-purity solid and solution formats for preclinical experiments and is intended for research use only, not for human therapeutic use.

  • Sodium channel blocker with reported analgesic activity.
  • High purity suitable for research applications (99.4%).
  • Available as powder and as a DMSO solution.
  • Stable when stored under recommended conditions for powder and solutions.
  • Intended for research use only; not for human use.

Catalog No. 50-002-21119 Supplier Medchemexpress LLC Supplier No. HY1455585MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bliretrigine is a research-stage sodium channel blocker supplied for laboratory studies of pain and neuronal function. It is provided in high-purity solid and solution formats for preclinical experiments and is intended for research use only, not for human therapeutic use.

  • Sodium channel blocker with reported analgesic activity.
  • High purity suitable for research applications (99.4%).
  • Available as powder and as a DMSO solution.
  • Stable when stored under recommended conditions for powder and solutions.
  • Intended for research use only; not for human use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.